Repurposing topical triclosan for cutaneous leishmaniasis: Preclinical efficacy in a murine Leishmania (L.) amazonensis model
暂无分享,去创建一个
S. R. Uliana | N. Taniwaki | A. Tempone | J. Q. Reimão | J. Guerra | J. T. Mesquita | M. Romanelli | Cristiana de Melo Trinconi Trinconi Cm
[1] Igor Cestari,et al. The current drug discovery landscape for trypanosomiasis and leishmaniasis: Challenges and strategies to identify drug targets , 2020, Drug development research.
[2] J. Augereau,et al. Design, Synthesis and Efficacy of Hybrid Triclosan‐gold Based Molecules on Artemisinin‐resistant Plasmodium falciparum and Leishmania infantum Parasites , 2020, ChemistrySelect.
[3] Ross D. King,et al. Plasmodium dihydrofolate reductase is a second enzyme target for the antimalarial action of triclosan , 2018, Scientific Reports.
[4] L. Leon,et al. Leishmaniasis treatment: update of possibilities for drug repurposing. , 2018, Frontiers in bioscience.
[5] S. Robledo,et al. Triclosan-caffeic acid hybrids: Synthesis, leishmanicidal, trypanocidal and cytotoxic activities. , 2017, European journal of medicinal chemistry.
[6] G. Wynne,et al. Efficacy of a series of alpha-pyrone derivatives against Leishmania (L.) infantum and Trypanosoma cruzi. , 2017, European journal of medicinal chemistry.
[7] S. Sundar,et al. Voacamine alters Leishmania ultrastructure and kills parasite by poisoning unusual bi‐subunit topoisomerase IB , 2017, Biochemical pharmacology.
[8] P. Denny,et al. Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art , 2017, Parasitology.
[9] R. Arenas,et al. Leishmaniasis: a review , 2017, F1000Research.
[10] T. Rosenau,et al. Mechanism of ascaridole activation in Leishmania , 2017, Biochemical pharmacology.
[11] Cristiana T. Trinconi,et al. Chemotherapy of leishmaniasis: present challenges , 2017, Parasitology.
[12] M. Doležal,et al. Enoyl acyl carrier protein reductase inhibitors: an updated patent review (2011 – 2015) , 2016, Expert opinion on therapeutic patents.
[13] Cristiana T. Trinconi,et al. Efficacy of tamoxifen and miltefosine combined therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis. , 2016, The Journal of antimicrobial chemotherapy.
[14] R. J. Alves,et al. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis. , 2016, Veterinary parasitology.
[15] R. Tukey,et al. Triclosan: A Widespread Environmental Toxicant with Many Biological Effects. , 2016, Annual review of pharmacology and toxicology.
[16] V. Ferrières,et al. Leishmania cell wall as a potent target for antiparasitic drugs. A focus on the glycoconjugates. , 2015, Organic & biomolecular chemistry.
[17] H. Ramadan,et al. Triclosan and triclosan-loaded liposomal nanoparticles in the treatment of acute experimental toxoplasmosis. , 2015, Experimental parasitology.
[18] S. Robledo,et al. Synthesis, Leishmanicidal and Cytotoxic Activity of Triclosan-Chalcone, Triclosan-Chromone and Triclosan-Coumarin Hybrids , 2014, Molecules.
[19] T. A. da Costa-Silva,et al. Activity of imidazole compounds on Leishmania (L.) infantum chagasi: reactive oxygen species induced by econazole , 2013, Molecular and Cellular Biochemistry.
[20] N. Taniwaki,et al. Lethal action of the nitrothiazolyl-salicylamide derivative nitazoxanide via induction of oxidative stress in Leishmania (L.) infantum. , 2013, Acta tropica.
[21] H. F. de Andrade,et al. Biodistribution of meglumine antimoniate in healthy and Leishmania (Leishmania) infantum chagasi-infected BALB/c mice , 2013, Memorias do Instituto Oswaldo Cruz.
[22] Cristiana T. Trinconi,et al. Parasite burden in Leishmania (Leishmania) amazonensis-infected mice: validation of luciferase as a quantitative tool. , 2013, Journal of microbiological methods.
[23] T. C. White,et al. Triclosan Antagonizes Fluconazole Activity against Candida albicans , 2012, Journal of dental research.
[24] A. Tempone,et al. Investigation into in vitro anti-leishmanial combinations of calcium channel blockers and current anti-leishmanial drugs. , 2011, Memorias do Instituto Oswaldo Cruz.
[25] D. Muñoz,et al. Synthesis and leishmanicidal activity of quinoline–triclosan and quinoline–eugenol hybrids , 2011, Medicinal Chemistry Research.
[26] D. C. Miguel. Caracterização da atividade de tamoxifeno no tratamento da leishmaniose experimental e investigação sobre seus mecanismos de ação. , 2011 .
[27] N. Alexander,et al. Safety and Efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial , 2011, Trials.
[28] Xuming Deng,et al. In Vitro Interaction between Fluconazole and Triclosan against Clinical Isolates of Fluconazole-Resistant Candida albicans Determined by Different Methods , 2011, Antimicrobial Agents and Chemotherapy.
[29] E. E. Almeida-Amaral,et al. Reactive Oxygen Species Production and Mitochondrial Dysfunction Contribute to Quercetin Induced Death in Leishmania amazonensis , 2011, PloS one.
[30] Bhavna Chawla,et al. Drug targets in Leishmania , 2010, Journal of parasitic diseases : official organ of the Indian Society for Parasitology.
[31] J. Wohlrab,et al. Antiseptic Efficacy of a Low-Dosed Topical Triclosan/Chlorhexidine Combination Therapy in Atopic Dermatitis , 2006, Skin Pharmacology and Physiology.
[32] D. Warhurst,et al. Modified Fixed-Ratio Isobologram Method for Studying In Vitro Interactions between Atovaquone and Proguanil or Dihydroartemisinin against Drug-Resistant Strains of Plasmodium falciparum , 2004, Antimicrobial Agents and Chemotherapy.
[33] F. Odds,et al. Synergy, antagonism, and what the chequerboard puts between them. , 2003, The Journal of antimicrobial chemotherapy.
[34] H. Schweizer. Triclosan: a widely used biocide and its link to antibiotics. , 2001, FEMS microbiology letters.
[35] C. Mateo,et al. Membranotropic effects of the antibacterial agent Triclosan. , 2001, Archives of biochemistry and biophysics.
[36] R. Lyons,et al. Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I. , 2001, International journal for parasitology.
[37] V. Yardley,et al. A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis. , 2000, International journal of antimicrobial agents.
[38] J. Chalmers,et al. The importance of drug combinations for effective control of hypertension. , 1999, Clinical and experimental hypertension.
[39] J. Berman,et al. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin. , 1999, The Journal of parasitology.
[40] Antoni R. Slabas,et al. Molecular basis of triclosan activity , 1999, Nature.
[41] I. Gilbert,et al. Design, synthesis, and evaluation of inhibitors of trypanosomal and leishmanial dihydrofolate reductase. , 1999, Journal of medicinal chemistry.
[42] D. Andreu,et al. The plasma membrane of Leishmania donovani promastigotes is the main target for CA(1-8)M(1-18), a synthetic cecropin A-melittin hybrid peptide. , 1998, The Biochemical journal.
[43] P. A. Leonard,et al. Triclosan: applications and safety. , 1996, American journal of infection control.
[44] C. Corbett,et al. A fast method for processing biologic material for electron microscopic diagnosis in infectious disease. , 1992, Ultrastructural pathology.
[45] C. Hansch,et al. Selective inhibition of Leishmania dihydrofolate reductase and Leishmania growth by 5-benzyl-2,4-diaminopyrimidines. , 1988, Molecular and biochemical parasitology.
[46] M. Koyama,et al. An improved colorimetric assay for interleukin 2. , 1986, Journal of immunological methods.
[47] J El-On,et al. Topical treatment of cutaneous leishmaniasis. , 1986, The Journal of investigative dermatology.
[48] H. J. Cleave. Acanthocephala from China. I. New Species and New Genera from Chinese Fishes , 1928, Parasitology.
[49] H. Baylis. Observations on certain Cestodes of Rats, with an Account of a New Species of Hymenolepis , 1922, Parasitology.